Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepside.

Pharmacokinetic modeling and simulation was used to derive an optimized, body weight-based dosing regimen, which allows for achievement of extended emodepside exposures above target concentrations while maintaining acceptable tolerability margins.